Ahmed I. Abdelaziz

AUC Avenue
New Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

YAP/TAZ knockdown reduces lipid droplet accumulation in hepatic cells through a putative SBDSP1/miR-29a-5p/LDLR regulatory axis.

YAP/TAZ knockdown reduces lipid droplet accumulation in hepatic cells through a putative SBDSP1/miR-29a-5p/LDLR regulatory axis.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: March 26, 2026

Sexual Dimorphism in Metabolic Dysfunction-Associated Steatotic Liver Disease: The Emerging Role of Non-Coding RNAs.

Sexual Dimorphism in Metabolic Dysfunction-Associated Steatotic Liver Disease: The Emerging Role of Non-Coding RNAs.

Journal: Comprehensive Physiology

Published: March 11, 2026

Association between the subcellular localization of host proteins and gut microbiome and metabolome in metabolic dysfunction-associated steatotic liver disease: a pilot study.

Association between the subcellular localization of host proteins and gut microbiome and metabolome in metabolic dysfunction-associated steatotic liver disease: a pilot study.

Journal: Frontiers in molecular biosciences

Published: September 11, 2025

Pilot study: predicting the interplay between FOXO1 and its downstream long non-coding RNAs in HCC.

Pilot study: predicting the interplay between FOXO1 and its downstream long non-coding RNAs in HCC.

Journal: Frontiers in oncology

Published: August 26, 2025

Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophies.

Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophies.

Journal: Inflammation and regeneration

Published: August 04, 2025

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.

Journal: International journal of cancer

Published: March 13, 2025

MEIS1: From functional versatility to post-transcriptional/translational regulation.

MEIS1: From functional versatility to post-transcriptional/translational regulation.

Journal: Life sciences

Published: February 15, 2025

MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells.

MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells.

Journal: Frontiers in oncology

Published: November 05, 2024

Interaction Between Malat1 and miR-499-5p Regulates Meis1 Expression and Function with a Net Impact on Cell Proliferation.

Interaction Between Malat1 and miR-499-5p Regulates Meis1 Expression and Function with a Net Impact on Cell Proliferation.

Journal: Cells

Published: November 04, 2024

OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma.

OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma.

Journal: BMC gastroenterology

Published: June 09, 2024

Drug repurposing of argatroban, glimepiride and ranolazine shows anti-SARS-CoV-2 activity via diverse mechanisms.

Drug repurposing of argatroban, glimepiride and ranolazine shows anti-SARS-CoV-2 activity via diverse mechanisms.

Journal: Heliyon

Published: January 21, 2024

Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC.

Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC.

Journal: Life sciences

Published: June 02, 2022

Showing 1-12 of 56

Last Updated: 09/26/2026